MIN/Sp/AU/CAMH3/6 TB Page 29 Notwithstanding, latest available information 46 indicates that only 69% of 42 countries that submitted reports had uninterrupted supply of first line anti-TB drugs at both the central and peripheral levels during 2006. This is a significant short fall with regard to Universal Access to essential TB treatment. For the treatment of drug resistant TB, only 65.4% of countries that reported some drug resistant TB cases had organized treatment programmes. Furthermore, as of January 2008, only 9 countries 47 had applied and been approved to access concessionary priced second line drugs from the Green Light Committee (GLC) of the Stop TB Partnership. This facility is available to all DOTS based TB Control programmes and should be utilized more widely than is currently the case. 5.4: Resource mobilization Adequate financial, human and logistic resources are a pre-requisite for implementation of TB control activities, as for other health services. Scale up towards universal access will entail even more funding and human resources. While donor funding provides significant additional resources, the best way to ensure sustainability is through allocation of national resources. There is insufficient information to determine national funding for TB Control as most activities are implemented within primary health care services without clear ear marking for TB control. During the past five years, external funding for TB control activities has increased significantly. The Global Fund to Fight AIDS, TB and Malaria (GFATM) has been the single most important source. During rounds 1-7 from 2002-2007, approximately 953 million USD (representing 37% of total available grants globally) was approved for TB Control activities in the African Region. Notwithstanding, this has not been marched with timely spending and has not translated into increased case detection and treatment success rates all round. Despite the progress in tuberculosis control, the Region has failed in achieving the global targets for tuberculosis control. While DOTS has expanded, covering 94% of the regional population and treatment success is high (82%), the case detection rate is only 44%. To improve case detection, the regional plan to Stop TB was developed as part of the global plan 2006– 2015. The budgetary need for the period of 2006 to 2015 indicated in the Plan is US$ 3.1 billion in the Region. Support to countries was enhanced and partnership development promoted. 46 WHO Global TB Report 2008 Burkina Faso, DRC, Guinea Conakry, Kenya, Lesotho, Mozambique, Rwanda, Tanzania (preapproval stage) and Uganda 47